Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
05/06/2014 | US8715952 Acetaminophen assay |
05/06/2014 | US8715951 Highly sensitive immunoassays and antibodies for detection of blood factor VIII |
05/06/2014 | US8715950 Kits for luminogenic and nonluminogenic multiplex assays |
05/06/2014 | US8715943 Methods for improving inflammatory bowel disease diagnosis |
05/06/2014 | US8715939 Compositions, methods and kits to detect adenovirus nucleic acids |
05/06/2014 | US8715938 Reversible di-nucleotide terminator sequencing |
05/06/2014 | US8715937 Mutation detection assay |
05/06/2014 | US8715936 Method of determining types I, II, III, IV or V or methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample |
05/06/2014 | US8715935 Standardized method and kit for the quantification of hepatitis A virus |
05/06/2014 | US8715934 Single-molecule PCR on microparticles in water-in-oil emulsions |
05/06/2014 | US8715933 Assay methods using nicking endonucleases |
05/06/2014 | US8715932 Nucleic acid sequencing |
05/06/2014 | US8715931 Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer |
05/06/2014 | US8715930 Loading molecules onto substrates |
05/06/2014 | US8715929 Synthetic operon |
05/06/2014 | US8715928 Molecular-based method of cancer diagnosis and prognosis |
05/06/2014 | US8715927 Inhibition of DNA polymerases to augment chemotherapeutic and antimicrobial agents |
05/06/2014 | US8715926 Biomarkers for the detection of head and neck tumors |
05/06/2014 | US8715925 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
05/06/2014 | US8715924 Process for determining the concentration of nucleic acids |
05/06/2014 | US8715923 Protein scaffolds and viral particles for detecting analytes |
05/06/2014 | US8715922 Virus causing respiratory tract illness in susceptible mammals |
05/06/2014 | US8715921 Method of diagnosing apoplectic stroke/asymptomatic brain infarction using acrolein content |
05/06/2014 | US8715694 Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein |
05/06/2014 | US8715693 Neurovirulent strain of the West Nile virus and uses thereof |
05/06/2014 | US8715688 Method for identification, isolation and production of antigens to a specific pathogen |
05/06/2014 | US8715683 RANK ligand polypeptides |
05/06/2014 | US8715646 Methods of determining need for anti-coagulation therapy |
05/06/2014 | US8715643 TDP-43-storing cell model |
05/06/2014 | CA2743731C Method of modulating the proliferation of medullary thyroid carcinoma cells |
05/06/2014 | CA2588420C Device and method for detection of analytes |
05/06/2014 | CA2579885C Association of protein polymorphisms with coronary heart disease |
05/06/2014 | CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
05/06/2014 | CA2439175C Opiate receptors |
05/01/2014 | WO2014066909A1 High density nanopore polynucleotide sequencer |
05/01/2014 | WO2014066905A2 Reducing background fluorescence in mems materials by low energy ion beam treatment |
05/01/2014 | WO2014066902A1 Hybrid nanopore device with optical detection and methods of using same |
05/01/2014 | WO2014066894A1 Biomarkers for nod2 and/or rip2 activity related application |
05/01/2014 | WO2014066888A1 High-throughput mutagenized cell screening system for selective single cell extraction |
05/01/2014 | WO2014066864A2 Androgen receptor variants and methods for making and using |
05/01/2014 | WO2014066848A1 Super-enhancers and methods of use thereof |
05/01/2014 | WO2014066796A2 Breast cancer prognosis signatures |
05/01/2014 | WO2014066749A2 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b and respiratory syncytial virus |
05/01/2014 | WO2014066704A1 Integrated multiplex target analysis |
05/01/2014 | WO2014066553A1 Devices and methods for manipulating components in a fluid sample |
05/01/2014 | WO2014066481A1 Methods and kits for detection of a pathogen in sugarcane |
05/01/2014 | WO2014066382A2 Assay for screening of anti-viral compounds that inhibit specific interaction interfaces between cullin5 and an elonginb/ elonginc/cbf-beta/hiv-1 vif complex |
05/01/2014 | WO2014066217A1 Hla typing using selective amplification and sequencing |
05/01/2014 | WO2014066184A1 Monitoring mantle cell lymphoma clonotypes in peripheral blood after immunotransplant |
05/01/2014 | WO2014066179A1 Template switch-based methods for producing a product nucleic acid |
05/01/2014 | WO2014066177A1 The use of oxidizing and non-oxidizing biocides for control of bacteria tolerant to stabilized-oxidant treatment |
05/01/2014 | WO2014065760A1 Methods for determining resistance against molecules targeting proteins |
05/01/2014 | WO2014065756A1 Assay for the parallel detection of biological material based on pcr |
05/01/2014 | WO2014065753A1 Direct visual detection of nucleic acid using gold nanoparticles |
05/01/2014 | WO2014065596A1 Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof |
05/01/2014 | WO2014065410A1 Method and kit for dna typing of hla gene |
05/01/2014 | WO2014065395A1 Rna preparation method |
05/01/2014 | WO2014065330A1 Cell observation device, electrical stimulation device, and cell observation method |
05/01/2014 | WO2014065329A1 Cell observation device, and cell observation method |
05/01/2014 | WO2014065323A1 Test method and test kit for psychiatric ailments |
05/01/2014 | WO2014065192A1 Nucleic acid extraction device and manufacturing method of said device, nucleic acid extraction method and nucleic acid sequence analysis method |
05/01/2014 | WO2014065191A1 Infection-evaluation-system model |
05/01/2014 | WO2014065047A1 Artificial bioluminescent enzyme |
05/01/2014 | WO2014064526A2 Methylation markers predictive for drug response |
05/01/2014 | WO2014064465A1 Method for detecting cation leaks |
05/01/2014 | WO2014064444A1 Droplet interfaces |
05/01/2014 | WO2014064223A1 Method for specifically isolating nucleic acids |
05/01/2014 | WO2014064169A1 Direct nucleic acid amplification kit, reagent and method |
05/01/2014 | WO2014064002A1 Methods, compositions and devices for amplification of nucleic acids |
05/01/2014 | WO2014063651A1 Method for purifying nucleic acid and kit |
05/01/2014 | WO2014063433A1 Use of hla-b*1301 allele |
05/01/2014 | WO2014063427A1 Method for screening drugs and used for drug for promoting the crosslinking of extracellular matrix and use thereof |
05/01/2014 | WO2014063247A1 Cell analysis by mass cytometry |
05/01/2014 | WO2014037712A3 Hiv-1 detection |
05/01/2014 | WO2014037275A3 Treatment of wastewater, especially mine water containing sulfate and/or heavy metal |
05/01/2014 | WO2014036182A3 Diagnosis and treatment of autism spectrum disorder |
05/01/2014 | WO2014036040A3 Methods for diagnosis, prognosis and methods of treatment |
05/01/2014 | WO2014031640A3 Antibodies to aripiprazole and use thereof |
05/01/2014 | WO2014008263A3 Paramyxovirus and methods of use |
05/01/2014 | WO2014005010A3 Methods of treating breast cancer with gemcitabine therapy |
05/01/2014 | WO2014004124A3 Method for amplification gene fusion complexes |
05/01/2014 | WO2013152186A8 Methods and compositions for 6-phosphogluconate dehydrogenase (6-pgd) as a target for lung cancer therapy |
05/01/2014 | WO2013141842A3 Genome-based drug management systems |
05/01/2014 | WO2013049702A9 Systems and methods for biological analysis |
05/01/2014 | WO2013035074A9 Method for assaying plasminogen in a liquid medium, associated compositions and kit |
05/01/2014 | WO2013009979A3 Compositions and methods for suppressing gene expression of p53 and clusterin |
05/01/2014 | WO2012177817A3 Systems and methods for identifying a contributor's str genotype based on a dna sample having multiple contributors |
05/01/2014 | WO2012145459A3 Glucose and insulin sensors and methods of use thereof |
05/01/2014 | WO2012129517A3 Evaluating protein expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer |
05/01/2014 | US20140123346 Genetic loci associated with iron deficiency tolerance in soybean |
05/01/2014 | US20140121363 Bioreactive Agents |
05/01/2014 | US20140121287 Molecular gram stain |
05/01/2014 | US20140121165 Induction of the Mitochondrial Permeability Transition |
05/01/2014 | US20140121133 SERUM/PLASMA MicroRNAs AND USES THEREOF |
05/01/2014 | US20140121130 Method of determining the prognosis of hepatocellular carcinomas using a multigene signature associated with metastasis |
05/01/2014 | US20140121128 Method for the prognosis of breast cancer based on the expression of the gene pin1 in combination with mutations in the gene tp53 |
05/01/2014 | US20140121126 Methods of detecting axl and gas6 in cancer patients |
05/01/2014 | US20140121124 Compositions and methods for the identification of inhibitors of retroviral infection |
05/01/2014 | US20140121122 Method for Detecting Transcription Factor-Protein Interactions |
05/01/2014 | US20140120629 Nucleic acid structure complex including nucleic acids, raman-active molecules, and metal particles, method of preparing the same, and method of detecting target material by using the nucleic acid structure complex |